Literature DB >> 26121576

Comment on: HMGB1-dependent and -independent autophagy.

Peter Huebener1, Geum Youn Gwak, Robert F Schwabe.   

Abstract

HMGB1 (high mobility group box 1), a ubiquitously expressed DNA-binding nucleoprotein, has not only been attributed with important functions in the regulation of gene expression but is thought to function as an important damage-associated molecular pattern in the extracellular space. Recently, conditional Hmgb1 deletion strategies have been employed to overcome the perinatal mortality of global Hmgb1 deletion and to understand HMGB1 functions under disease conditions. From these studies, it has become evident that HMGB1 is not required for normal organ function. However, the different conditional ablation strategies have yielded contradictory results in some disease models. With nearly complete recombination in all transgenic mouse models, the main reason for opposite results is likely to lie within different targeting strategies. In summary, different targeting strategies need to be taken into account when interpreting HMGB1 functions, and further efforts need to be undertaken to compare these models side by side.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121576      PMCID: PMC4590679          DOI: 10.1080/15548627.2015.1054593

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  10 in total

1.  The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

Authors:  Peter Huebener; Jean-Philippe Pradere; Celine Hernandez; Geum-Youn Gwak; Jorge Matias Caviglia; Xueru Mu; John D Loike; Robert F Schwabe
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

2.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice.

Authors:  S Calogero; F Grassi; A Aguzzi; T Voigtländer; P Ferrier; S Ferrari; M E Bianchi
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

3.  High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo.

Authors:  Peter Huebener; Geum-Youn Gwak; Jean-Philippe Pradere; Catarina M Quinzii; Richard Friedman; Chyuan-Sheng Lin; Chad M Trent; Ingmar Mederacke; Enpeng Zhao; Dianne H Dapito; Yuxi Lin; Ira J Goldberg; Mark J Czaja; Robert F Schwabe
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

4.  Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.

Authors:  Emilie A Bard-Chapeau; Andrea L Hevener; Shinong Long; Eric E Zhang; Jerrold M Olefsky; Gen-Sheng Feng
Journal:  Nat Med       Date:  2005-04-10       Impact factor: 53.440

5.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

6.  Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.

Authors:  Sayaka Inokuchi; Tomonori Aoyama; Kouichi Miura; Christoph H Osterreicher; Yuzo Kodama; Katsumi Miyai; Shizuo Akira; David A Brenner; Ekihiro Seki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

7.  Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis.

Authors:  Janie L Baratta; Anthony Ngo; Bryan Lopez; Natasha Kasabwalla; Kenneth J Longmuir; Richard T Robertson
Journal:  Histochem Cell Biol       Date:  2009-03-03       Impact factor: 4.304

8.  Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection.

Authors:  Hai Huang; Gary W Nace; Kerry-Ann McDonald; Sheng Tai; John R Klune; Brian R Rosborough; Qing Ding; Patricia Loughran; Xiaorong Zhu; Donna Beer-Stolz; Eugene B Chang; Timothy Billiar; Allan Tsung
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

9.  HMGB1-dependent and -independent autophagy.

Authors:  Xiaofang Sun; Daolin Tang
Journal:  Autophagy       Date:  2014-08-13       Impact factor: 16.016

10.  Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.

Authors:  Alexander Jais; Elisa Einwallner; Omar Sharif; Klaus Gossens; Tess Tsai-Hsiu Lu; Selma M Soyal; David Medgyesi; Daniel Neureiter; Jamile Paier-Pourani; Kevin Dalgaard; J Catharina Duvigneau; Josefine Lindroos-Christensen; Thea-Christin Zapf; Sabine Amann; Simona Saluzzo; Florian Jantscher; Patricia Stiedl; Jelena Todoric; Rui Martins; Hannes Oberkofler; Simone Müller; Cornelia Hauser-Kronberger; Lukas Kenner; Emilio Casanova; Hedwig Sutterlüty-Fall; Martin Bilban; Karl Miller; Andrey V Kozlov; Franz Krempler; Sylvia Knapp; Carey N Lumeng; Wolfgang Patsch; Oswald Wagner; J Andrew Pospisilik; Harald Esterbauer
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

  10 in total
  4 in total

1.  LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.

Authors:  Zhanqiang Zheng; Guanglin Zhang; Xiaodong Liang; Tianxiao Li
Journal:  Mol Cell Biochem       Date:  2020-09-29       Impact factor: 3.396

Review 2.  The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review.

Authors:  Xuanbin Wang; Longchao Xiang; Hongliang Li; Ping Chen; Yibin Feng; Jingxuan Zhang; Nian Yang; Fei Li; Ye Wang; Quifang Zhang; Fang Li; Fengjun Cao
Journal:  Int J Mol Sci       Date:  2015-09-17       Impact factor: 5.923

3.  Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells.

Authors:  Xiufeng Liu; Juanjuan Wu; Menglin Fan; Chen Shen; Wenling Dai; Yini Bao; Ji-Hua Liu; Bo-Yang Yu
Journal:  Cell Death Dis       Date:  2018-10-15       Impact factor: 8.469

Review 4.  Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases.

Authors:  Meng Li; Ping Gao; Junping Zhang
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.